Literature DB >> 17220237

Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population.

Ho-Jin Kang1, Im-Sook Song, Ho Jung Shin, Woo-Young Kim, Choong-Hee Lee, Joo-Cheol Shim, Hong-Hao Zhou, Sang Seop Lee, Jae-Gook Shin.   

Abstract

Genetic variants of three human organic cation transporter genes (hOCTs) were extensively explored in a Korean population. The functional changes of hOCT2 variants were evaluated in vitro, and those genetic polymorphisms of hOCTs were compared among different ethnic populations. From direct DNA sequencing, 7 of 13 coding variants were nonsynonymous single-nucleotide polymorphisms (SNPs), including four variants from hOCT1 (F160L, P283L, P341L, and M408V) and three from hOCT2 (T199I, T201M, and A270S), whereas 6 were synonymous SNPs. The linkage disequilibrium analysis presented for three independent LD blocks for each hOCT gene showed no significant linkage among all three hOCT genes. The transporter activities of MDCK cells that overexpress the hOCT2-T199I, -T201M, and -A270S variants showed significantly decreased uptake of [(3)H]methyl-4-phenylpyridinium acetate (MPP(+)) or [(14)C]tetraethylammonium compared with those cells that overexpress wild-type hOCT2, and the estimated kinetic parameters of these variants for [(3)H]MPP(+) uptake in oocytes showed a 2- to 5-fold increase in K(m) values and a 10- to 20-fold decrease in V(max) values. The allele frequencies of the five functional variants hOCT1-P283L, -P341L, and hOCT2-T199I, -T201M, and -A270S were 1.3, 17, 0.7, 0.7, and 11%, respectively, in a Korean population; the frequency distributions of these variants were not significantly different from those of Chinese and Vietnamese populations. These findings suggest that genetic variants of hOCTs are not linked among three genes in a Korean population, and several of the hOCT genetic variants cause decreased transport activity in vitro compared with the wild type, although the clinical relevance of these variants remains to be evaluated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220237     DOI: 10.1124/dmd.106.013581

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  30 in total

1.  Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Authors:  Morne Du Plessis; Brendon Pearce; Clifford Jacobs; Nisreen Hoosain; Mongi Benjeddou
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

2.  Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.

Authors:  Hwa Yoon; Hea-Young Cho; Hee-Doo Yoo; Se-Mi Kim; Yong-Bok Lee
Journal:  AAPS J       Date:  2013-02-16       Impact factor: 4.009

3.  Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.

Authors:  Wai Johnn Sam; Orsolya Roza; Yuen Yi Hon; Raul M Alfaro; Karim A Calis; James C Reynolds; Jack A Yanovski
Journal:  J Clin Pharmacol       Date:  2016-08-23       Impact factor: 3.126

4.  Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.

Authors:  Claudia Lanvers-Kaminsky; Jason A Sprowl; Ingrid Malath; Dirk Deuster; Maria Eveslage; Eberhard Schlatter; Ron Hj Mathijssen; Joachim Boos; Heribert Jürgens; Antionette G Am Zehnhoff-Dinnesen; Alex Sparreboom; Giuliano Ciarimboli
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

5.  Organic cation transporter variation and response to smoking cessation therapies.

Authors:  Andrew W Bergen; Harold S Javitz; Ruth Krasnow; Martha Michel; Denise Nishita; David V Conti; Christopher K Edlund; Pui-Yan Kwok; Jennifer B McClure; Richard B Kim; Sharon M Hall; Rachel F Tyndale; Timothy B Baker; Neal L Benowitz; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2014-08-20       Impact factor: 4.244

6.  Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.

Authors:  R Moaddel; F Bighi; R Yamaguchi; S Patel; S Ravichandran; I W Wainer
Journal:  Anal Biochem       Date:  2010-03-03       Impact factor: 3.365

Review 7.  Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.

Authors:  Sook Wah Yee; Deanna J Brackman; Elizabeth A Ennis; Yuichi Sugiyama; Landry K Kamdem; Rebecca Blanchard; Aleksandra Galetin; Lei Zhang; Kathleen M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2018-05-31       Impact factor: 6.875

8.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

9.  Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.

Authors:  T F Spracklen; A A Vorster; L Ramma; S Dalvie; R S Ramesar
Journal:  Pharmacogenomics J       Date:  2016-07-26       Impact factor: 3.550

10.  Population pharmacokinetic study of memantine: effects of clinical and genetic factors.

Authors:  Muriel Noetzli; Monia Guidi; Karsten Ebbing; Stephan Eyer; Laurence Wilhelm; Agnès Michon; Valérie Thomazic; Abdel-Messieh Alnawaqil; Sophie Maurer; Serge Zumbach; Panteleimon Giannakopoulos; Armin von Gunten; Chantal Csajka; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.